Brought to you by 
Acclarent's Series C brings in $35mm
09 Mar 2021
Executive Summary
Acclarent (surgical device for ENT indications) raised $35mm through its Series C private financing round. New investors Meritech Capital Partners (lead) and Delphi Ventures were joined by existing backers New Enterprise Associates and Versant Ventures. Individual investors also participated.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Acclarent's Series C brings in $35mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice